SignIn
Kerala Kaumudi Online
Tuesday, 08 July 2025 12.20 AM IST

COVID-19: Phase-3 trial of COVAXIN to begin in UP's Lucknow, Gorakhpur from October

Increase Font Size Decrease Font Size Print Page
covaxin

LUCKNOW: The Uttar Pradesh government on Thursday announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start in Lucknow and Gorakhpur from October.


"The phase-3 trial of COVAXIN being developed by Bharat Biotech will start in Lucknow and Gorakhpur from October," said Uttar Pradesh Principal Health Secretary Amit Mohan Prasad here in a press conference.

The Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech for the development of the COVAXIN.

Meanwhile, Congress leader Deepak Singh on Thursday wrote a letter to Chief Minister Yogi Adityanath and requested to increase testing for COVID-19 in Uttar Pradesh.

According to the Union Health Ministry as of Thursday, there are 61,698 active cases in the state with 3,02,689 recovered people and 5,299 deaths.

TAGS: COVAXIN, COVID VACCINE
JOIN THE DISCUSSION
KERALA KAUMUDI EPAPER
TRENDING IN INDIA
TRENDING IN INDIA
X
Lorem ipsum dolor sit amet
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
We respect your privacy. Your information is safe and will never be shared.